scholarly journals Disability as a predictor of breast cancer screening uptake: A population-based study of 57,328 women

2019 ◽  
Vol 27 (4) ◽  
pp. 194-200
Author(s):  
Emma Ross ◽  
Aideen Maguire ◽  
Michael Donnelly ◽  
Adrian Mairs ◽  
Clare Hall ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Northern Ireland ◽  
Breast Cancer Screening ◽  
Breast Screening ◽  
The United States ◽  
Ageing Population ◽  
Screening Uptake ◽  
National Breast ◽  
The Impact

Objective Despite a growing body of evidence suggesting inequalities in breast cancer screening uptake in the United States for women with disabilities, few attempts have been made to examine whether this association applies to the United Kingdom. We conducted the first population-wide study investigating the impact of disability on uptake of breast cancer screening in Northern Ireland. Methods Breast screening records extracted from the National Breast Screening System were linked to the Northern Ireland Longitudinal Study. This identified a cohort of 57,328 women who were followed through one complete three-year screening cycle of the National Health Service Breast Screening Programme in Northern Ireland. The presence of disability was identified from responses to the 2011 Census. Results Within this cohort, 35.8% of women reported having at least one chronic disability, and these individuals were 7% less likely to attend compared with those with no disability (odds ratio 0.93; 95% confidence interval 0.89–0.98). Variation in the degree of disparity observed was evident according to the type and number of comorbid disabilities examined. Conclusion This is the first population-wide study in Northern Ireland to identify disparities in breast screening uptake for women with chronic disabilities, in particular, those with multimorbidity. This is of particular concern, given the projected rise in the prevalence of disability associated with the ageing population.

scholarly journals Does poor mental health explain socio-demographic gradients in breast cancer screening uptake? A population-based study

2019 ◽  
Vol 30 (3) ◽  
pp. 538-543
Author(s):  
Emma Ross ◽  
Aideen Maguire ◽  
Michael Donnelly ◽  
Adrian Mairs ◽  
Clare Hall ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mental Health ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Screening ◽  
Poor Mental Health ◽  
Targeted Interventions ◽  
Screening Uptake ◽  
The Uk ◽  
The Impact

Abstract Background Research from the USA indicates disparities in breast cancer screening uptake for women with poor mental health. However, no attempt has been made to examine the contribution of poor mental health to socio-demographic variations in breast screening uptake. The current study aims to examine the impact of self-reported chronic poor mental health on attendance at breast screening in the UK, and to what extent this explains socio-demographic inequalities in screening uptake. Methods Breast screening records were linked to 2011 Census records within the Northern Ireland Longitudinal Study. This identified a cohort of 57 328 women who were followed through one 3-year screening cycle of the National Health Service Breast Screening Programme. Information on mental health status, in addition to other individual and household-level attributes, was derived from the 2011 Census. Logistic regression was employed to calculate odds ratios (ORs) and 95% confidence intervals (CIs) of attendance at screening. Results 10.7% of women in the cohort reported poor mental health, and in fully adjusted analyses, these individuals were 23% less likely to attend breast screening (OR 0.77; 95% CI 0.73–0.82). Although poor mental health was a strong predictor of screening uptake, it did not explain the observed inequalities in uptake by socio-economic status, marital status, or area of residence. Conclusions This study provides novel evidence of inequalities in breast screening uptake for women with chronic poor mental health in the UK. Targeted interventions are necessary to ensure equitable screening access and to enhance overall mortality benefit.

scholarly journals Socio-Territorial Inequities in the French National Breast Cancer Screening Programme – A Cross-Sectional Multilevel Study

2021 ◽  
Author(s):  
Quentin Rollet ◽  
Élodie Guillaume ◽  
Ludivine Launay ◽  
Guy Launoy
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Travel Time ◽  
Breast Cancer Screening ◽  
Screening Programme ◽  
Opportunistic Screening ◽  
Screening Uptake ◽  
Breast Cancer Screening Programme ◽  
National Breast ◽  
Cancer Screening Programme

Abstract Background. France implemented in 2004 the French National Breast Cancer Screening Programme (FNBCSP). Despite national recommendations, this programme coexists with non-negligible opportunistic screening practices.Aim. Analyse socio-territorial inequities in the 2013-2014 FNBCSP campaign in a large sample of the eligible population.Method. Analyses were performed using three-level hierarchical generalized linear model. Level one was a 10% random sample of the eligible population in each département (n = 397 598). For each woman, age and travel time to the nearest accredited radiology centre were computed. These observations were nested within 22 250 IRIS, for which the European Deprivation Index (EDI) is defined. IRIS were nested within 41 départements, for which opportunistic screening rates and gross domestic product based on purchasing power parity were available, deprivation and the number of radiology centres for 100 000 eligible women were computed. Results. Organized screening uptake increased with age (OR1SD = 1.05 [1.04 – 1.06]) and decreased with travel time (OR1SD = 0.94 [0.93 – 0.95]) and EDI (OR1SD = 0.84 [0.83 – 0.85]). Between départements, organized screening uptake decreased with opportunistic screening rate (OR1SD = 0.84 [0.79 – 0.87]) and départements deprivation (OR1SD = 0.91 [0.88 – 0.96]). Association between EDI and organized screening uptake was weaker as opportunistic screening rates and as département deprivation increased. Heterogeneity in FNBCSP participation decreased between IRIS by 36% and between départements by 82%. Conclusion. FNBCSP does not erase socio-territorial inequities. The population the most at risk of dying from BC is thus the less participating. More efforts are needed to improve equity.

scholarly journals Breast cancer and breast screening: perceptions of Chinese migrant women living in New Zealand

2014 ◽  
Vol 6 (2) ◽  
pp. 135 ◽  
Author(s):  
Wei Zhang ◽  
Sally Rose ◽  
Alison Foster ◽  
Sue Pullon ◽  
Beverley Lawton
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
New Zealand ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Screening ◽  
Breast Health ◽  
Migrant Women ◽  
Breast Clinic ◽  
National Breast

INTRODUCTION: Migrant Chinese constitute a significant and increasing proportion of New Zealand women. They have lower rates of participation in breast cancer screening than other New Zealanders, but reasons for this are unknown. The aim of this study was to investigate factors affecting Chinese women’s understanding of, and access to, breast health services, to better understand reasons for low participation in screening and their experiences of breast cancer clinic care. METHODS: The participants were 26 Chinese migrant women – 19 recruited in the community and seven recruited from 17 eligible women attending a breast clinic between 2008 and 2010 in Wellington, New Zealand. The design was that of a qualitative study, using semi-structured interviews and thematic content analysis. FINDINGS: There were low levels of awareness about the national breast screening programme and limited engagement with preventive primary care services. Concerns about privacy and a range of communication difficulties were identified that related to oral language, lack of written information in Chinese, and limited understanding about Chinese perceptions of ill health and traditional Chinese medicine by New Zealand health professionals. CONCLUSION: Addressing communication barriers for Chinese migrant women has the potential to raise awareness about breast cancer and breast health, and to increase successful participation in breast cancer screening. Greater efforts are needed to ensure this group has an understanding of, and is engaged with a primary care provider. Such efforts are key to improving health for this growing sector of the New Zealand population. KEYWORDS: Breast cancer; Chinese; mammography; mass screening; New Zealand

scholarly journals Breast cancer screening patterns in Jamaican women: review of the largest national mammography clinic

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sheray N. Chin ◽  
Derria Cornwall ◽  
Derek I. Mitchell ◽  
Michael E. McFarlane ◽  
Joseph M. Plummer
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Cancer Diagnosis ◽  
Mammographic Screening ◽  
Screening Mammography ◽  
Screening Guidelines ◽  
National Breast ◽  
Jamaican Women ◽  
The Impact

Abstract Background Breast cancer is the leading cause of cancer and cancer related deaths in Jamaican women. In Jamaica, women often present with advanced stages of breast cancer, despite the availability of screening mammography for early detection. The utilization of screening mammography for early breast cancer diagnosis seems to be limited, and this study investigated the national patterns of mammographic screening and the impact of mammography on the diagnosis of breast cancer in Jamaica. Methods A retrospective analysis of the records of the largest mammography clinic in Jamaica was done for the period January 2011 to December 2016. Descriptive statistics was performed on relevant patient characteristics with calculation of rates and proportions; cross-tabulations were utilized to assess relationship of covariates being studied on the outcomes of interest. Results are reported in aggregate form with no identifiable patient data. Results 48,203 mammograms were performed during the study period. 574 women (1.2%) had mammograms suspicious for breast cancer with median age of 57 years (range 30–95 years); 35% were under the age of 50. 4 women with suspicious findings had undergone ‘screening mammography’, with the remaining having ‘diagnostic mammography’. 38% reported previous mammograms, with a mean interval of 8 years between previous normal mammogram and mammogram suspicious for breast cancer. Median age at first screening mammogram was 51 years (range 41–77). Conclusion Breast cancer screening mammography is underutilized in Jamaica. An organized national breast cancer screening programme is recommended to improve adherence to international breast cancer screening guidelines.

scholarly journals Evaluation of The Pink Luminous Breast LED-Based Technology Device as a Screening Tool for the Early Detection of Breast Abnormalities

2021 ◽  
Author(s):  
Fernando Ocasio-Villa ◽  
Luisa Morales-Torres ◽  
Norma Velez-Medina ◽  
Juan C Orengo ◽  
Edu B. Suarez-Martinez
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Early Detection ◽  
Breast Cancer Screening ◽  
Gold Standard ◽  
Breast Screening ◽  
Screening Tool ◽  
Red Light ◽  
High Sensitivity ◽  
The United States

Breast cancer is the leading cause of sex-specific female cancer death in the United States. Detection at earlier stages contributes to decrease the mortality rate. The mammography is considered the gold standard for breast cancer screening with an estimate sensitivity of 86.9% and a specificity 88.9%. However, these values are negatively affected by the breast, which is consider a risk factor for developing breast cancer. Herein, we validate the novel LED-based FDA Class I medical device Pink Luminous Breast (PLB) by the comparison of two breast screening imaging-based tests using a double blinded approach. The PLB works by emitting a LED red light with a harmless spectrum of 640-800 nanometers, the trans-illuminated breast tissue allows the observation of abnormalities represented by darker or shadowing areas. In this study, we evaluated the sensitivity and specificity of the PLB device as a screening tool for the early detection of breast abnormalities when compared with the mammography as the gold standard. Our results showed that PLB device has a high sensitivity (89.6%) and specificity (96.4%) for detecting breast abnormalities comparable to the adjusted mammography values: 86.3% and 68.9% respectively. Importantly, the percentage of positive dense tissue findings from a total of 340 events was 266 (78.2%) using PLB vs. 248 (72.9%) detected by the mammography. A 100% of the participants responded in a survey that they feel comfortable using the device and visualizing their breast without feeling pain or discomfort during the examination. The PLB positive validation vs the mammography brings the potential to be recommended for routinely breast screening at non-clinical settings. The PLB provides a rapid, non-invasive, portable, and easy-to-use tool for breast screening that can complement the home-based BSE technique or the CBE. In addition, the PLB can be conveniently used for screening breasts with surgical implants. PLB provides an accessible and painless breast cancer screening tool. The use of this device is not intended to replace the mammography as the gold standard for breast screening but rather to use it as an adjunct or complement tool as part of more efficient earlier detection strategies and contribute to decrease this health disparity.

scholarly journals Mapping variation in breast cancer screening: Where to intervene?

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
C Padilla ◽  
P Soler Michel ◽  
V Vieira
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Cancer Mortality ◽  
Participation Rate ◽  
Participation Rates ◽  
Screening Uptake ◽  
Screening Participation ◽  
Cancer Screening Participation ◽  
The Impact

Abstract Introduction Mammography screening can reduce breast cancer mortality among women aged 50 years and older. Small geographic areas with lower breast cancer screening uptake may reflect gaps in screening efforts. Our objective was to identify the geographic variations of breast cancer screening uptake among women aged 50-74 years in the Lyon Metropole area, France. Methods We used spatial regression models within a generalized additive framework to determine the clusters of census blocks with significantly lower risk of breast cancer screening uptake. Census block-level data on breast cancer screening participation rates were calculated for women aged 50-74 years who did a mammography between 2015-2016 after being invited with a letter by the cancer screening organization. Using smoothed risk maps adjusting for covariates, we estimated the impact of the spatial distribution of deprivation index, part of opportunistic screening on breast cancer screening participation. Results Between 2015 and 2016, the participation rate of organized breast cancer screening was 49.9%. As hypothesized, women living in highly deprived census blocks had lower participation rates compared to less deprived. However, women living in rural areas with fewer certified mammography services than in urban areas had the highest participation rate. Spatial analyses identified four clusters, one located in an urban area and three in suburban areas. Conclusions Our analysis indicates that depending on the location of the cluster, the influence came from different variables. Knowing the impact of site-specific risk factors is important for implementing an appropriate prevention intervention. Key messages Spatial analysis for cancer screening can help to improve health initiatives. This study contributes to a better understanding of the cluster-specific factors that explain geographic disparities.

Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies

2021 ◽  
pp. 096914132098618
Author(s):  
Daniel B Kopans
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Breast Screening ◽  
Demographic Factors ◽  
Random Assignment ◽  
National Breast ◽  
Early Results ◽  
Allocation Process ◽  
Clinical Breast Examinations

Despite overwhelming evidence of a major reduction in deaths, the debate about the efficacy of breast cancer screening has continued for over 50 years. The poor results in the Canadian National Breast Screening Studies (CNBSS) have been used to challenge the benefits shown by the other randomized, controlled trials. They continue to be used in assessing the value of breast cancer screening despite their unblinded allocation process, which first identified women with breast abnormalities and then assigned them on open lists allowing for nonrandom assignment, compromising the trials and rendering their results unreliable. There were, statistically significantly, more women with advanced cancers who were assigned to the screening arm in CNBSS1. The early results for CNBSS1 showed an excess of women dying in the screening arm, and an (otherwise inexplicable) greater than 90%, 5-year survival for the control women. The failure of random assignment also explains why the clinically evident cancers were larger in the screening arms than the cancers in the “usual care” arms, despite the fact that the screened women underwent very intense clinical breast examinations each year by highly skilled examiners. The claim that balanced demographic factors prove random assignment is also false. Nonrandom allocation of a hundred or more women with clinically evident abnormalities would have no detectable influence on the distribution of demographic factors. In summary, policy decisions about mammography should not be influenced by the results of the CNBSS.

Sign in / Sign up

Export Citation Format

Share Document